We recently published a list of 10 Low Price High Volume Stocks to Buy Now. In this article, we are going to take a look at ...

Apple heads this list from the Management Top 250, followed by Microsoft and Walmart ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

Last year, more than $7.5 billion globally went to companies applying advances in artificial intelligence to health-related areas such as medical services and pharmaceutical development, per ...

For Charlotte airport passengers, Florida’s theme park capital of the world, the Big Apple and Beantown were some of the top U.S. destinations in 2024. Charlotte Douglas International Airport recently ...

Sanofi's deep partnership with OpenAI could be a huge differentiating factor. Check out why I rate SNY stock a buy.

In 2024, global private equity and venture capital transaction value and volume in biotechnology declined to their lowest ...

President Donald Trump said he would likely impose tariffs on automobile, semiconductor and pharmaceutical imports of around ...

Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...